SEVERE EOSINOPHILIC ACOS (ASTHMA-COPD OVERLAP)

Clinical trials for SEVERE EOSINOPHILIC ACOS (ASTHMA-COPD OVERLAP) explained in plain language.

Never miss a new study

Get alerted when new SEVERE EOSINOPHILIC ACOS (ASTHMA-COPD OVERLAP) trials appear

Sign up with your email to follow new studies for SEVERE EOSINOPHILIC ACOS (ASTHMA-COPD OVERLAP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Blood and lung clues may predict biologic success in severe ACOS

Knowledge-focused Not yet recruiting

This study aims to find markers in blood and lung scans that can predict how well patients with severe eosinophilic ACOS (a mix of asthma and COPD) will respond to biologic drugs like benralizumab, mepolizumab, or dupilumab. Researchers will follow 500 adults for 48 weeks after s…

Matched conditions: SEVERE EOSINOPHILIC ACOS (ASTHMA-COPD OVERLAP)

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused

Last updated May 26, 2026 08:33 UTC

SEVERE EOSINOPHILIC ACOS (ASTHMA-COPD OVERLAP)

Get alerted when new SEVERE EOSINOPHILIC ACOS (ASTHMA-COPD OVERLAP) trials appear

Blood and lung clues may predict biologic success in severe ACOS